Brief: Xvivo Perfusion Q3 EBITDA Raises To SEK 5.2 Million
Oct 26 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* Q3 NET SALES SEK 40.9 MILLION VERSUS SEK 32.3 MILLION YEAR
AGO
* Q3 EBITDA SEK 5.2 MILLION VERSUS SEK 4.1 MILLION YEAR AGO
Source text for Eikon: ID:nWkr7JWQgW
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength